Gwen A. Morgan

Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs

James K. Hennan, Robert E. Swillo, Gwen A. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 85 citations

Effect of tiplaxtinin (PAI‐039), an orally bioavailable PAI‐1 antagonist, in a rat model of thrombosis

James K. Hennan, Gwen A. Morgan, Robert E. Swillo et al. · Journal of Thrombosis and Haemostasis · 2008 · 62 citations

Thrombopoiesis, Thrombosis, Molecular Pharmacology +6

Synthesis and Secretion of Plasminogen Activator Inhibitor-1 by Human Preadipocytes

David L. Crandall, Elaine Quinet, Gwen A. Morgan et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 56 citations

Sc Preadipocytes, Immunology, Cellular Pharmacology +25

The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model

Eric I. Rossman, Kun Liu, Gwen A. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 53 citations

Evaluation of PAI-039 [{1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1 H-indol-3-yl}(oxo)acetic Acid], a Novel Plasminogen Activator Inhibitor-1 Inhibitor, in a Canine Model of Coronary Artery Thrombosis

James K. Hennan, Hassan Elokdah, Mauricio Leal et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 42 citations